Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2462 (LINC02462) is a member of the lincRNA family, comprising transcripts longer than 200 nucleotides that do not overlap protein-coding genes and are not translated into protein[3]. LincRNAs are transcribed by RNA polymerase II and may be involved in gene regulation, chromatin remodeling, and cellular differentiation[1][3]. While some lincRNAs have clear biological functions and are involved in disease processes, there is currently no published evidence detailing the specific biological roles or therapeutic relevance of LINC02462[1][3]. As with other lincRNAs, its investigation as a biomarker or functional component in disease remains a topic of ongoing research, but no specific associations or clinical applications have been validated for LINC02462.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2462 (LINC02462).